Strengthening Core Businesses and Improving Productivity

「ディスプレイメーカー向けＦＰＣの販売は減少したものの、医療機器メーカー、カメラメーカー及び産業機器メーカーをはじめとしたセットメーカー向け量産案件等の受注増により販売が増加したことから、売上高は増加いたしました。損益については、委託量産製品の減少及び社内製造品の売上高増加による売上総利益率の上昇に伴う影響により増益となりました。」

「Although sales of FPCs for display manufacturers (Note 3) declined, sales increased because orders for mass-production projects and other products for set-product manufacturers (Note 4), including camera, medical equipment, and industrial equipment manufacturers, increased. Profit increased due to the impact of a higher gross profit margin resulting from lower sales of purchased products and higher sales of in-house manufactured products. As a result, revenue was ¥1,323 million, up 14.1% year on year, and segment profit was ¥295 million, up 38.7%.」

「Although sales of FPCs to medical equipment and display manufacturers declined, revenue increased because mass-production projects and general prototyping projects for industrial equipment manufacturers and other set-product manufacturers increased. Profit increased due to lower labor costs and other expenses resulting from the voluntary retirement program, as well as the resulting improvement in the gross profit margin from higher sales of in-house manufactured products. As a result, revenue was ¥2,409 million, up 6.3% year on year, and segment profit was ¥500 million, up 50.5%.」

「Although sales of FPCs to medical-device and display manufacturers declined, sales of FPCs to set manufacturers, including camera manufacturers, increased, resulting in higher revenue. Profit increased due to lower labor costs and other expenses from voluntary employee departures, as well as the effect of a higher gross margin resulting from increased sales of in-house manufactured products. As a result, revenue was ¥1,159 million, up 0.5% year on year, and segment profit was ¥213 million, up 30.2%.」

「The Group aims to enhance corporate value by rebuilding its business model and optimising its portfolio, focusing on growth areas including medical devices, high-speed communications and automotive applications, and providing high-value-added products and services. It also plans to build businesses that will become new pillars of earnings by deepening and integrating the core technologies cultivated in each business to create synergies.」

「Although sales of FPCs (※3) to medical device manufacturers increased, sales declined because prolonged inventory adjustments for consumer products and industrial equipment reduced FPC sales to other set makers (※4), camera manufacturers and others. Profit declined due to the impact of lower sales and an increase in the ratio of labor costs to sales associated with wage increases and other factors. Accordingly, revenue was ¥1,152 million, down 12.4% year on year, and segment profit was ¥163 million, down 33.1%.」

「Sales declined because prolonged inventory adjustments for consumer products and industrial equipment reduced FPC sales to other set makers, display manufacturers and others. Profit increased despite the impact of lower sales, as improvements in the cost structure and a decrease in merchanting products raised the gross profit margin.」

「As a result, revenue was ¥2,419 million, down 9.2% year on year, and segment profit was ¥399 million, down 31.8%.」

「As a result, revenue was ¥1,874 million, down 4.7% year on year, and segment profit was ¥317 million, down 23.7%.」

「Although sales of FPCs for medical device manufacturers declined because high-performance FPC (※3) projects decreased, and sales to other set makers (※4) declined because in-house mass-production projects decreased, sales to display manufacturers increased as demand for industrial touch panels and other products remained firm, while sales to camera manufacturers increased as development of high-performance models became more active. Revenue increased, but profit declined because the gross profit margin fell due to an increase in merchanting products and other factors, while personnel expenses and costs associated with higher sales at overseas bases increased. Accordingly, revenue was ¥1,316 million, up 4.8% year on year, and segment profit was ¥244 million, down 12.1%.」

「Sales declined because demand for FPCs (※3) for medical devices paused, reducing high-performance product projects, and orders for in-house mass-production projects for industrial equipment for set makers (※4) declined. Profit decreased because the decline in sales and the increase in merchanting sales caused the gross profit margin to fall. Accordingly, revenue was ¥621 million, down 1.9% year on year, and segment profit was ¥98 million, down 30.5%.」

「Although prototyping projects for FPCs for industrial equipment (Note 3) declined as the market showed signs of a pause, orders for in-house mass-production projects for industrial equipment, including industrial inkjet printers and drones, and for medical equipment remained strong, resulting in higher net sales. In terms of profit and loss, although higher orders for in-house mass-production projects increased the cost of sales, profit increased due to the impact of higher net sales. As a result, net sales were ¥1,966 million, up 9.6% year on year, and segment profit was ¥416 million, up 7.2%.」

「As a result, revenue was ¥1,256 million, up 6.9% year on year, and segment profit was ¥278 million, up 8.4%.」

「Although orders for FPC prototyping projects for set makers (※3) declined as the development of materials for electronic mobile devices and other projects paused, sales increased as orders for mass-production projects from set makers, including camera and medical device manufacturers, rose. Profit increased as a result of the higher sales. Accordingly, revenue was ¥633 million, up 7.6% year on year, and segment profit was ¥142 million, up 7.6%.」

「Profit increased as the gross profit margin rose due to higher orders for prototyping projects and improved yield, while personnel expenses and other selling, general and administrative expenses declined.」

「The Group will work to improve price competitiveness through further reductions in manufacturing costs and improve the quality of high-difficulty products by shortening lead times through the optimisation of staffing by reviewing production processes, including automation, improving product design and reducing defect rates at each process stage.」

「The Group will flexibly review its sales and regional strategies for its core electronic circuit board business, while developing its competitive strengths, namely its technological capability to provide integrated support from prototyping through mass production and its thorough quality control, in order to strengthen the core business's technological capabilities and ability to propose products. In addition, the Group will pursue further productivity improvements by accumulating cost-reduction initiatives covering production equipment running costs, materials procurement and other areas, implementing efficient production and inventory management, renewing production equipment and promoting the automation of operations with robots.」